HLS Therapeutics Inc (DE:74D)
FRANKFURT:74D
Holding DE:74D?
Track your performance easily

HLS Therapeutics Inc (74D) Financial Statements

0 Followers

HLS Therapeutics Inc Financial Overview

HLS Therapeutics Inc's market cap is currently ―. The company's EPS TTM is €-0.637; its P/E ratio is -3.48; HLS Therapeutics Inc is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is €-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 14.52M$ 12.47M$ 15.86M$ 16.04M$ 16.42M
Gross Profit$ 12.22M$ 10.70M$ 13.33M$ 14.17M$ 14.64M
EBIT$ 1.10M$ -3.51M$ -2.71M$ -5.03M$ 254.00K
EBITDA$ 6.96M$ 2.41M$ 4.33M$ 3.17M$ 8.62M
Net Income Common Stockholders$ -5.68M$ -6.11M$ -5.40M$ -6.90M$ -1.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 32.52M$ 19.44M$ 21.95M$ 21.81M$ 20.93M
Total Assets$ 191.32M$ 197.75M$ 209.06M$ 215.23M$ 226.82M
Total Debt$ 85.11M$ 6.88M$ 6.88M$ 7.10M$ 13.01M
Net Debt$ 52.59M$ -12.56M$ -15.08M$ -14.71M$ -7.92M
Total Liabilities$ 108.62M$ 108.69M$ 111.36M$ 113.43M$ 115.38M
Stockholders Equity$ 82.71M$ 89.07M$ 97.70M$ 101.80M$ 111.44M
Cash Flow-
Free Cash Flow$ 15.77M$ 776.00K$ 3.72M$ 5.33M$ 2.53M
Operating Cash Flow$ 2.52M$ 778.00K$ 3.73M$ 5.37M$ 2.67M
Investing Cash Flow$ 13.25M$ -2.00K$ -14.00K$ -40.00K$ -135.00K
Financing Cash Flow$ -2.58M$ -3.03M$ -3.89M$ -4.29M$ -2.95M
Currency in USD

HLS Therapeutics Inc Earnings and Revenue History

HLS Therapeutics Inc Debt to Assets

HLS Therapeutics Inc Cash Flow

HLS Therapeutics Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis